eOD-GT8 60mer mRNA Vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for eOD-GT8 60mer mRNA Vaccine, covering 2024-05-01 to 2024-05-01. Get the full timeline:
Most recent: Clinical Trial Update: A Phase 1 Study to Evaluate the Safety and Immunogenicity of eOD-GT8 60mer mRNA Vaccine (mRNA-1644) and Core-g28v2 60mer mRNA Vaccine (mRNA-1644v2-Core) [Phase 1]